One of two imported COVID cases fully vaccinated with three doses of BioNTech

Taiwan’s Central Epidemic Command Center (CECC) today announced two new cases of COVID-19 imported from abroad, including one Taiwanese citizen who was fully vaccinated with three doses of the Pfizer-BioNTech vaccine while residing in the United States.

CECC spokesman Chuang Jen-hsiang (莊人祥) said that the woman (case #16,458) is aged in her 20s and had the third dose of the BioNTech vaccine on September 10. The woman had a negative test report taken within three days of boarding her flight in the United States on October 6, and another negative test after arrival in Taiwan.

During the quarantine period, the case reported that the air-conditioning in her hotel room was too cold, and she had developed a cough. A consequent PCR test returned a positive result with a Ct value of 36.

The CECC said that one previous imported COVID-19 case had received three vaccine shots, however, the third shot had been administered less than 14 days previous to entry. Therefore, that case was recorded as a breakthrough infection in a person fully vaccinated with two doses.

Today’s case is recorded as the first breakthrough infection in a person fully vaccinated with three doses of a COVID-19 vaccine.

Taiwan English News is an independent publication with no corporate funding. If you found this article informative, and would like to support my work, please buy me a coffee or support me on Patreon. Subscribe to Taiwan English News for free to receive the latest news via email. Advertising queries are welcome. Share, like, comment below.

2 thoughts on “One of two imported COVID cases fully vaccinated with three doses of BioNTech

  • October 21, 2021 at 3:41 pm
    Permalink

    Fully vaccinated is newspeak for fully effed.

    Reply
  • October 21, 2021 at 6:37 pm
    Permalink

    “The case…” “The woman case…” Such human warmth and caring consideration reflected in these words. NOT. This whole story makes one highly suspicious on many levels.

    Reply

Comment and discuss this story: While all opinions are welcome, comments will not be approved if they contain inflammatory speech.

This site uses Akismet to reduce spam. Learn how your comment data is processed.